TrialJapanese journal of clinical oncology2017

Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).

Kenjiro Namikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.